Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.09

(11.8%)

FLWS

$5.75

(9.45%)

ACCO

$4.23

(3.17%)

ARLP

$23.92

(1.48%)

AUIAF

$0.09

(-1.77%)

AZZ

$117.29

(3.48%)

BTBT

$3.1

(2.48%)

BTM

$3.92

(0.15%)

CVKD

$13.18

(4.27%)

LCE:CA

$0.28

(1.82%)

COCP

$1.22

(0.41%)

CDRO

(1.45%)

CVGI

$1.94

(3.19%)

LODE

$2.97

(3.85%)

CMTL

$2.5

(2.88%)

CNDT

$2.94

(4.82%)

CXW

$20.88

(1.02%)

CMLS

$0.14

(12.2%)

DRCT

$0.4

(0.27%)

DLHC

$5.75

(-1.88%)

SSP

$2.89

(1.76%)

ELDN

$2.5

(3.09%)

EVC

$2.5

(2.88%)

EDRY

$12.79

(2.4%)

ESEA

$63.84

(0.42%)

FAT

$1.96

(2.61%)

RAIL

$8.92

(2.41%)

GDEV

$17.02

(1.87%)

GOVX

$0.67

(-0.82%)

GOCO

$4.86

(1.25%)

GHM

$55.11

(5.41%)

GLDD

$12.52

(4.59%)

GYRE

$7.02

(1.45%)

HMENF

$1.54

(6.7%)

III

$5.52

(2.6%)

IPOOF

$8.99

(-2.12%)

KELYA

$14.44

(3.74%)

KTOS

$79.18

(4.54%)

LUCK

$9.74

(0.1%)

MAIA

$1.6

(4.22%)

MGROF

$0.45

(-3.13%)

NTRB

$7.11

(2.75%)

OCGN

$1.31

(-0.76%)

PERF

$1.96

(-0.51%)

QMCI

$0.17

(13.19%)

RGP

$5.48

(3.72%)

SGA

$12.61

(3.07%)

SHWZ

(0%)

SHIP

$9.08

(1.91%)

SLQT

$2.06

(1.23%)

SKYX

$1.31

(0.77%)

SNAL

$0.99

(6.61%)

GEO

$21.98

(1.71%)

ODP

$22.06

(1.75%)

TNXP

$28.15

(1.59%)

TSQ

$6.88

(0.66%)

TZOO

$10.21

(4.61%)

UNCY

$4.03

(-0.25%)

VVX

$59.88

(4.68%)

VNCE

$2.76

(8.26%)

XELB

$1.45

(0.69%)

ZOMDF

$0.09

(11.8%)

FLWS

$5.75

(9.45%)

channelchek-in

‌

9/18/2025

Roche to Acquire 89bio in $3.5 Billion Deal to Advance MASH Treatment Pipeline

Swiss pharmaceutical leader Roche has announced an agreement to acquire clinical-stage biopharmaceutical company 89bio, Inc. in a deal valued at up to $3.5 billion. The acquisition is set to strengthen Roche’s cardiovascular, renal, and metabolism portfolio, particularly its capabilities in treating metabolic dysfunction-associated steatohepatitis (MASH).

2 min read